Drug: GB-102

Phase 2

Phase 2

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

3 competitors in Neovascular Age-Related Macular Degeneration

Drug Information

Target Indication

Neovascular Age-Related Macular Degeneration

Clinical Trial

Last updated: 1/22/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

VMAR

Vision Marine Technologies Inc.

Related Pipeline

Dry Eye Syndromes

Stargardt Disease

Dry Age-related Macular Degeneration

Fuchs Endothelial Dystrophy

Corneal Erosion